I would like to suggest the inclusion of the two formulas cited above. We are in need of using them in COVID-19 times.
The first one is to measure the Risk of coagulopathy in sepsis and thus the indication of anticoagulation in COVID patients as well.

The second one is to estimate the presence of HLH, another possibility of treatment with immunosuppressive treatment in COVID-19 patients.

All the best,

Luciano Pilla Pinto
Brazil